BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12891651)

  • 1. Magnetic resonance spectroscopy of neurotransmitters in human brain.
    Novotny EJ; Fulbright RK; Pearl PL; Gibson KM; Rothman DL
    Ann Neurol; 2003; 54 Suppl 6():S25-31. PubMed ID: 12891651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of propofol on the levels of neurotransmitters in normal human brain: a magnetic resonance spectroscopy study.
    Zhang H; Wang W; Gao W; Ge Y; Zhang J; Wu S; Xu L
    Neurosci Lett; 2009 Dec; 467(3):247-51. PubMed ID: 19853639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders.
    Moore GJ; Galloway MP
    Psychopharmacol Bull; 2002; 36(2):5-23. PubMed ID: 12397837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region-dependent alterations in glutamate and GABA measured by high-resolution magnetic resonance spectroscopy following acute binge inhalation of toluene in juvenile rats.
    O'Leary-Moore SK; Galloway MP; McMechan AP; Hannigan JH; Bowen SE
    Neurotoxicol Teratol; 2007; 29(4):466-75. PubMed ID: 17466488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
    Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC
    Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brain metabolism alterations in patients with anorexia nervosa observed in 1H-MRS].
    Grzelak P; Gajewicz W; Wyszogrodzka-Kucharska A; Rotkiewicz A; Stefańczyk L; Góraj B; Rabe-Jabłońska J
    Psychiatr Pol; 2005; 39(4):761-71. PubMed ID: 16237980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct detection of brain acetylcholine synthesis by magnetic resonance spectroscopy.
    Katz-Brull R; Koudinov AR; Degani H
    Brain Res; 2005 Jun; 1048(1-2):202-10. PubMed ID: 15921662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of GABA measurements using 2D J-resolved magnetic resonance spectroscopy.
    Lymer K; Haga K; Marshall I; Sailasuta N; Wardlaw J
    Magn Reson Imaging; 2007 Jun; 25(5):634-40. PubMed ID: 17540274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain MRI and proton MRS findings in infants and children with respiratory chain defects.
    Dinopoulos A; Cecil KM; Schapiro MB; Papadimitriou A; Hadjigeorgiou GM; Wong B; deGrauw T; Egelhoff JC
    Neuropediatrics; 2005 Oct; 36(5):290-301. PubMed ID: 16217703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with 13C MRS in vivo.
    Ross B; Lin A; Harris K; Bhattacharya P; Schweinsburg B
    NMR Biomed; 2003; 16(6-7):358-69. PubMed ID: 14679500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy for studies of neurotransmission in vivo.
    Mason GF
    Psychopharmacol Bull; 2003; 37(2):26-40. PubMed ID: 14566212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation.
    McCoy CL; McIntyre DJ; Robinson SP; Aboagye EO; Griffiths JR
    Br J Cancer Suppl; 1996 Jul; 27():S226-31. PubMed ID: 8763886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies.
    Bianchi MC; Sgandurra G; Tosetti M; Battini R; Cioni G
    Biosci Rep; 2007 Jun; 27(1-3):69-85. PubMed ID: 17510789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging central neurochemical alterations in chronic pain with proton magnetic resonance spectroscopy.
    Harris RE; Clauw DJ
    Neurosci Lett; 2012 Jun; 520(2):192-6. PubMed ID: 22445845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo 1H-[13C]-NMR spectroscopy of cerebral metabolism.
    de Graaf RA; Mason GF; Patel AB; Behar KL; Rothman DL
    NMR Biomed; 2003; 16(6-7):339-57. PubMed ID: 14679499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging and spectroscopy of brain development.
    Hüppi PS
    Magn Reson Imaging Clin N Am; 2001 Feb; 9(1):1-17, vii. PubMed ID: 11278181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy: an emerging technology in pediatric neurology research.
    Novotny E; Ashwal S; Shevell M
    Pediatr Res; 1998 Jul; 44(1):1-10. PubMed ID: 9667363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectral analysis of multichannel MRS data.
    Sandgren N; Stoica P; Frigo FJ; Selén Y
    J Magn Reson; 2005 Jul; 175(1):79-91. PubMed ID: 15949751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy.
    Shibuya-Tayoshi S; Tayoshi S; Sumitani S; Ueno S; Harada M; Ohmori T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):249-56. PubMed ID: 17913322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.